Mid-Sized European M&A Fills Earnings Gap--And More?

Solvay's acquisition of France's Fournier suggests that there is value within Europe's family-owned, domestically-focused groups, and at good prices. The deal will boost Solvay's earnings until its own pipeline matures, although some question the potential for longer-term synergies.

By Melanie Senior

On one level, Solvay SA 's €1.3 billion ($1.7 billion) all-cash acquisition of Fournier Pharma makes perfect sense:...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Global Vision

More from In Vivo